Talis Biomedical Corporation (NASDAQ: TLIS) Stock Information | RedChip

Talis Biomedical Corporation (NASDAQ: TLIS) Listen to this Section


$4.30
+0.1600 ( +3.87% ) 15.0K

Talis Biomedical Corp is engaged in developing and commercializing products designed to enable molecular testing for infectious diseases and other conditions at the point-of-care. Its Talis One System is a molecular diagnostic platform developed to enable point-of-care testing for infectious diseases such as COVID-19.

Market Data


Open


$4.30

Previous close


$4.14

Volume


15.0K

Market cap


$7.93M

Day range


$3.99 - $4.31

52 week range


$3.75 - $9.60

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
nt Quarterly Reports 1 Aug 14, 2024
3 Insider transactions 1 Aug 14, 2024
3 Insider transactions 1 Aug 07, 2024
3 Insider transactions 1 Aug 07, 2024
8-k 8K-related 15 Aug 06, 2024
8-k 8K-related 12 Jun 25, 2024
8-k 8K-related 12 Jun 03, 2024
10-q Quarterly Reports 53 May 08, 2024
8-k 8K-related 12 May 03, 2024
8-k 8K-related 11 Apr 11, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.